DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Verstovsek S, Mesa RA, Gotlib J et al.
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.
N Engl J Med 2012;
366: 799-807
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.